1. Five drugs, including two from Novartis, win EMA endorsement —What’s next for Amarin’s stock after FDA panel recommendation — Shionogi antibiotic scores FDA ok— See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

10.2bn

Discussion in 'Galderma' started by anonymous, May 20, 2019 at 6:11 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Why did EQT pay so much? What will the return on investment be? Staying private for years while building big and IPO?
     
  2. anonymous

    anonymous Guest

    who am I?
    I’m a loser and have no vision but I also lead by fear? Clue Limited EB!
     
  3. anonymous

    anonymous Guest

    You are a completely ignorant and arrogant fool to write all that sh*t.

    Have you ever worked for a PE? I guess not. I don't think you know anything at all!

    I bet you are too busy drinking cool aid to think about those things. Poor you...all angry.
     
  4. anonymous

    anonymous Guest

    a private-equity firm wants to make money. it has to improve the value of the companies it buys. it tries to improve the performance of the acquired company, with an eye toward cashing out by selling it or taking it public. things will change around here
     
  5. anonymous

    anonymous Guest

    All companies want to make money, jackass. Spread your insecurities elsewhere.
     
  6. anonymous

    anonymous Guest

    evolus owns eqt you fools
     
  7. anonymous

    anonymous Guest

    Evolus doesn’t even own Evolus.
     
  8. anonymous

    anonymous Guest

    The only way the price makes sense is a major cost cutting and down-sizing is imminent. Wake up to PE controlled company reality. Been there once already, it sucks. It will start at the top with a full leadership change bringing in their own people as it should have a while ago for us.
     
  9. anonymous

    anonymous Guest

    Thanks, finally someone who gets it. Working for a PE ain’t no fun. Been there too.
     
  10. anonymous

    anonymous Guest

    You will become quite familiar with these terms

    Contractual / operational efficiencies
    Revenue leakage
    Dividend recapitalization
     
  11. anonymous

    anonymous Guest

    Goodbye Galderma!

    soon it will be EQT’s rules. We will be working for EQT’s investors. Decisions will be made in the best interests of the fund’s investors. Short term gains, profit optimization, revenue growth, operational and organizational improvements lie ahead of us

    It will no longer be about creating patient value
     
  12. anonymous

    anonymous Guest

    why so negative? Seriously! Enjoy what we have while we still have it... everything will be ok! You would be saying the same sh*** regardless pf who purchased us!
     
  13. anonymous

    anonymous Guest

    roller coaster ride ahead of us! buckle up if you don’t have the option of leaving
     
  14. anonymous

    anonymous Guest

    serioysly, the first thing they should do is cut your bonuses and comp by 40%. You are so o repaid and not that good face it.
     
  15. anonymous

    anonymous Guest

    i m good at it and I actually face my man lover ass and ballz before he goes down the Hershey highway.
     
  16. anonymous

    anonymous Guest

    so everything we have worked for legal or not is down the drain?
    now we get our slips?
    what about the shady docs and pharmacies?
     
  17. anonymous

    anonymous Guest

    were fine! This was the strategic partner they wanted! All good!
     
  18. anonymous

    anonymous Guest

    Get your resumes ready, don’t say you didn’t know.
     
  19. anonymous

    anonymous Guest

    You are so right!